Literature DB >> 25528144

Galactose-1-phosphate uridyltransferase dried blood spot quality control materials for newborn screening tests.

Barbara W Adam1, Sharon R Flores2, Yu Hou3, Todd W Allen4, Victor R De Jesus2.   

Abstract

OBJECTIVES: We aimed to prepare dried-blood-spot (DBS) quality control (QC) materials for galactose-1-phosphate uridyltransferase (GALT), to evaluate their stability during storage and use, and to evaluate their performance in five DBS GALT test methods. DESIGN AND METHODS: We prepared and characterized GALT-normal and GALT-deficient DBS materials and compared GALT activities in DBSs after predetermined storage intervals at controlled temperatures and humidities. External evaluators documented the suitability of the DBS QC materials for use in five GALT test methods.
RESULTS: GALT activity losses from DBSs stored in low (<30%) humidity for 14 days at 45°C, 35 days at 37°C, 91 days at room temperature, 182 days at 4°C, and 367 days at -20°C were 54%, 53%, 52% 23%, and 7% respectively. In paired DBSs stored in high humidity (>50%) for identical intervals, losses were: 45°C-68%; 37°C-79%; room temperature-72%, and 4°C-63%. GALT activities in DBSs stored at 4°C were stable throughout 19 excursions to room temperature. Twenty-five of 26 external evaluators, using five different GALT test methods, classified the GALT-deficient DBSs as "outside normal limits". All evaluators classified the GALT-normal DBSs as "within normal limits".
CONCLUSIONS: Most of the GALT activity loss from DBSs stored at elevated or room temperature was attributable to the effects of storage temperature. Most of the loss from DBSs stored at 4°C was attributable to the effects of elevated humidity. Loss from DBSs stored at -20°C was insignificant. The DBS materials were suitable for monitoring performance of all five GALT test methods.
Copyright © 2014 The Canadian Society of Clinical Chemists. All rights reserved.

Entities:  

Keywords:  Blood spots; Galactose-1-phosphate uridyltransferase; Galactosemia; Newborn screening; Quality control; Sample integrity

Mesh:

Substances:

Year:  2014        PMID: 25528144      PMCID: PMC4547523          DOI: 10.1016/j.clinbiochem.2014.12.009

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States.

Authors:  B W Adam; E M Hall; M Sternberg; T H Lim; S R Flores; S O'Brien; D Simms; L X Li; V R De Jesus; W H Hannon
Journal:  Clin Biochem       Date:  2011-09-21       Impact factor: 3.281

2.  Observations on heat/humidity denaturation of enzymes in filter-paper blood spots from newborns.

Authors:  Dennis E Freer
Journal:  Clin Chem       Date:  2005-04-21       Impact factor: 8.327

3.  National evaluation of US newborn screening system components.

Authors:  Bradford L Therrell; W Harry Hannon
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

4.  Newborn screening: toward a uniform screening panel and system--executive summary.

Authors: 
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

5.  Newborn screening fact sheets.

Authors:  Celia I Kaye; Frank Accurso; Stephen La Franchi; Peter A Lane; Northrup Hope; Pang Sonya; Schaefer G Bradley; Lloyd-Puryear Michele A
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

6.  Stabilities of hemoglobins A and S in dried blood spots stored under controlled conditions.

Authors:  Barbara W Adam; Dana L Chafin; Victor R De Jesús
Journal:  Clin Biochem       Date:  2013-05-20       Impact factor: 3.281

7.  A simple spot screening test for galactosemia.

Authors:  E Beutler; M C Baluda
Journal:  J Lab Clin Med       Date:  1966-07

Review 8.  Classical galactosaemia revisited.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2006-07-11       Impact factor: 4.982

9.  Multi-rule quality control for the age-related eye disease study.

Authors:  Samuel P Caudill; Rosemary L Schleicher; James L Pirkle
Journal:  Stat Med       Date:  2008-09-10       Impact factor: 2.373

Review 10.  Galactosemia: screening and diagnosis.

Authors:  E Beutler
Journal:  Clin Biochem       Date:  1991-08       Impact factor: 3.281

View more
  1 in total

1.  The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five Year Experience Assuring Newborn Screening Laboratory Quality.

Authors:  Víctor R De Jesús; Joanne V Mei; Suzanne K Cordovado; Carla D Cuthbert
Journal:  Int J Neonatal Screen       Date:  2015
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.